Organigram (NASDAQ:OGI) Announces Quarterly Earnings Results

Organigram (NASDAQ:OGI) announced its quarterly earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.02), Zacks reports. Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%.

Organigram Stock Performance

Organigram stock opened at $1.35 on Thursday. The business has a 50-day simple moving average of $1.57 and a 200 day simple moving average of $1.67. Organigram has a 52 week low of $1.29 and a 52 week high of $2.91.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.